Optimal application of stereotactic body radiotherapy and radiofrequency ablation treatment for different multifocal hepatocellular carcinoma lesions in patients with Barcelona Clinic Liver Cancer stage A4–B1: a pilot study

BACKGROUND: In clinical practice, many hepatocellular carcinoma (HCC) patients in Barcelona Clinical Liver Cancer (BCLC) stage A4–B1 cannot receive the curative treatments of liver transplantation, resection, and radiofrequency ablation (RFA), which are the recommended options according to liver can...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Feiqian, Numata, Kazushi, Takeda, Atsuya, Ogushi, Katsuaki, Fukuda, Hiroyuki, Nihonmatsu, Hiromi, Hara, Koji, Chuma, Makoto, Tsurugai, Yuichirou, Maeda, Shin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8557576/
https://www.ncbi.nlm.nih.gov/pubmed/34717577
http://dx.doi.org/10.1186/s12885-021-08897-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8557576/
https://www.ncbi.nlm.nih.gov/pubmed/34717577
http://dx.doi.org/10.1186/s12885-021-08897-z

Ejemplares similares